Carole Nuechterlein - Net Worth and Insider Trading
Carole Nuechterlein Net Worth
The estimated net worth of Carole Nuechterlein is at least $18 Million dollars as of 2024-12-27. Carole Nuechterlein is the Director, 10% Owner of Aligos Therapeutics Inc and owns about 441,038 shares of Aligos Therapeutics Inc (ALGS) stock worth over $18 Million. Details can be seen in Carole Nuechterlein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carole Nuechterlein has not made any transactions after 2023-10-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carole Nuechterlein
Carole Nuechterlein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carole Nuechterlein owns 7 companies in total, including Aligos Therapeutics Inc (ALGS) , BCTG Acquisition Corp (BCTG) , and Millendo Therapeutics Inc (MLND) among others .
Click here to see the complete history of Carole Nuechterlein’s form 4 insider trades.
Insider Ownership Summary of Carole Nuechterlein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALGS | Aligos Therapeutics Inc | 2023-10-25 | director |
| BCTG | BCTG Acquisition Corp | 2020-09-02 | director |
| MLND | Millendo Therapeutics Inc | 2020-06-22 | director |
 | | 2016-02-10 | director |
| | 2018-12-07 | director |
| | 2021-10-28 | director |
| | 2020-09-02 | director |
Carole Nuechterlein Latest Holdings Summary
Carole Nuechterlein currently owns a total of 1 stock. Carole Nuechterlein owns 441,038 shares of Aligos Therapeutics Inc (ALGS) as of October 25, 2023, with a value of $18 Million.
Latest Holdings of Carole Nuechterlein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALGS | Aligos Therapeutics Inc | 2023-10-25 | 441,038 | 41.15 | 18,148,714 |
Holding Weightings of Carole Nuechterlein
Carole Nuechterlein Form 4 Trading Tracker
According to the SEC Form 4 filings, Carole Nuechterlein has made a total of 1 transactions in Aligos Therapeutics Inc (ALGS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aligos Therapeutics Inc is the acquisition of 317,344 shares on October 25, 2023, which cost Carole Nuechterlein around $6 Million.
Insider Trading History of Carole Nuechterlein
- 1
Carole Nuechterlein Trading Performance
GuruFocus tracks the stock performance after each of Carole Nuechterlein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carole Nuechterlein is 13.9%. GuruFocus also compares Carole Nuechterlein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carole Nuechterlein within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Carole Nuechterlein's insider trading performs compared to the benchmark.
Performance of Carole Nuechterlein
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.5 | | | | | |
| Relative Return to S&P 500(%) | 7.6 | | | | | |
Carole Nuechterlein Ownership Network
Carole Nuechterlein Owned Company Details
What does Aligos Therapeutics Inc do?
Who are the key executives at Aligos Therapeutics Inc?
Carole Nuechterlein is the director of Aligos Therapeutics Inc. Other key executives at Aligos Therapeutics Inc include 10 percent owner Roche Holding Ltd , 10 percent owner Roche Finance Ltd , and Chief Medical Officer Matthew W. Mcclure .
Aligos Therapeutics Inc (ALGS) Insider Trades Summary
Over the past 18 months, Carole Nuechterlein made 1 insider transaction in Aligos Therapeutics Inc (ALGS) with a net purchase of 7,933,601.
In summary, during the past 3 months, insiders sold 0 shares of Aligos Therapeutics Inc (ALGS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aligos Therapeutics Inc (ALGS) were sold and 317,344 shares were bought by its insiders, resulting in a net purchase of 317,344 shares.
Aligos Therapeutics Inc (ALGS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aligos Therapeutics Inc Insider Transactions
Carole Nuechterlein Mailing Address
Above is the net worth, insider trading, and ownership report for Carole Nuechterlein. You might contact Carole Nuechterlein via mailing address: C/o Avexis, Inc., 2275 Half Day Road, Suite 160, Bannockburn Il 60015.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
